Skin Antiseptic Products Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Skin Antiseptic Products Market Analysis
The skin antiseptic products market is projected to register a CAGR of 7.5% during the forecast period.
The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, with the advent of the COVID-19 infection, the necessity for antiseptic products has increased significantly, to restrict the spread of the infection. For instance, an article titled 'Oral Antiseptics Against Coronavirus: In-Vitro and Clinical Evidence' published in the Journal of Hospital Infection in July 2021 indicated that oral antiseptics can be used in the inactivating and eradicating the coronaviruses, thereby leading to a lower risk of transmission via salivary droplets or aerosols. The article suggested the use of oral antiseptics such as povidone-iodine, hydrogen peroxide, chlorhexidine, and cetylpyridinium chloride to reduce the intra-oral viral load in COVID-19-positive patients. The increasing use of antiseptics during the COVID-19 pandemic significantly added to the market growth.
The demand for these products is increasing, due to a higher prevalence of Hospital Acquired Infections (HAIs), lack of sanitation and precaution, and increased use of surgical units and endoscope reprocesses. Furthermore, the global antiseptic industry is witnessing a higher rate of growth, due to increased expenditure on healthcare, elevated incidences of hospital-acquired infectious diseases, and increased awareness of cleanliness and disinfection measures. Skin antiseptic is used to maintain human or non-living germ-free. With COVID-19, there has been an increase in awareness about bacterial, viral, and fungal infections and their prevention with the use of antiseptics. This is expected to have a positive impact on the market growth.
Also, the increase in nosocomial infections poses a serious challenge to health care professionals globally during the COVID-19 pandemic. In September 2021, a study published in the Infection Control and Hospital Epidemiology titled "The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections in 2020: A Summary of Data Reported to The National Healthcare Safety Network" showed that there was a significant increase in the number of healthcare-associated infections (HAIs) in the year 2020 than the previous year. The rapid rise in HAIs is majorly attributed to the COVID-19 pandemic. Hospitals are found to boost their infection control protocols to avoid or destroy hospital-acquired infections for the patient and hospital staff's safety. Thus, there is an increasing demand for the skin antiseptics market to prevent the further spread of such hospital-acquired infections. These infections also present a significant economic burden at the societal level. However, a large percentage of HAIs are preventable through effective infection prevention and control measures. Thus, the increasing demand for the prevention of hospital-acquired infections is likely to add to the growth of the studied market during the forecast period.
Moreover, the recent antiseptic product launches by market players worldwide are adding to the market growth. For instance, in November 2021, Emami Limited launched the non-sticky antiseptic cream BoroPlus soft ayurvedic antiseptic cream in India. Also, in December 2021, MedLife Formulations Pvt. Ltd. launched Septicol antiseptic liquid, which is effective in killing or slowing down viruses, bacteria, and other harmful microorganisms. Such product launches are expected to significantly add to the growth of the studied market during the forecast period.
However, the side effects associated with the antiseptics and the risk of permeability are hindering the growth of the skin antiseptics market.
Skin Antiseptic Products Market Trends
This section covers the major market trends shaping the Skin Antiseptic Products Market according to our research experts:
Alcohols Segment is Expected to Dominate the Skin Antiseptic Products Market over the Forecast Period
The alcohol segment is expected to lead the market, owing to an increased usage of formulations for pre-injection and pre-operative skin preparation. Furthermore, the increasing demand for alcohol bases to be used in combination with other formulations, such as iodine and chlorhexidine, is fueling the segment's growth. Furthermore, it comprises antiseptic agents, such as isopropyl or ethyl, which are effective against different microbes. The sales of antiseptics that are alcohol-based increased significantly, due to the outbreak of COVID-19.
The rising assistance in the use of alcohol-based hand sanitizers is also adding to the segment's growth. According to an article titled 'Ethanol is indispensable for virucidal hand antisepsis: memorandum from the alcohol-based hand rub (ABHR) Task Force, WHO Collaborating Centre on Patient Safety, and the Commission for Hospital Hygiene and Infection Prevention (KRINKO), Robert Koch Institute, Berlin, Germany' published in the journal of Antimicrobial Resistance & Infection Control in July 2022, the World Health Organization Task Force ABHR and KRINKO recommended the use of ethanol as a biocidal ingredient in the hand rubs use in the healthcare department since ethanol is safe for the prevention of healthcare-associated infections and spread of antimicrobial resistance.
Moreover, the rise in the number of surgeries being performed around the world is likely to add to the growth of the segment. As per an article titled 'Trauma of Major Surgery: A Global Problem That is Not Going Away' published in the International Journal of Surgery in September 2020, on a global level, around 310 million major surgeries are performed each year with around 40 to 50 million surgeries in the United States and 20 million surgeries in Europe. The increase in the number of surgeries performed around the world is expected to add to the segmental growth.
In addition to the above-mentioned factors, the role of the market players plays a vital part in the segment growth. For instance, in April 2021, Wet Ones launched their liquid gel hand sanitizer and alcohol hand sanitizing wipes. The products are made with ethyl alcohol as their main ingredient. The increasing use of alcohol-based sanitizers and their product launches are likely to boost the growth of the studied segment over the forecast period.
Thus, the increasing prevalence of hospital-acquired infections and the increasing number of surgeries along with the product launches by market players are boosting the growth of the segment.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, the high prevalence of nosocomial infections in the region, and established healthcare infrastructure.
In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market. Also, the rising hospital-acquired infections in the countries are adding to the market growth. For instance, according to the Center for Disease Control and Prevention (CDC)'s Healthcare-Associated Infections (HAIs) report published in October 2021, in the United States, there was a 24% increase in the number of central line-associated bloodstream infections (CLABSIs) in the year 2020, as compared to the previous year. Also, the report indicated that the number of ventilator-associated events increased by 35% in the year 2020 compared to last year. The increase in the number of hospital-acquired infections in the country is expected to add to the growth of the skin antiseptics market over the forecast period.
Moreover, the recent activities by key market players in the region are also aiding the market growth. For example, in January 2022, the Ontario government supported a USD 10 million investment by Empack Spraytech Inc. in a new disinfectant wipe production facility in Barrie. The facility aims to produce over 4 million antiseptic wipes per day, to meet the rising demand in the region. Such activities are expected to boost the market growth in the region.
Thus, owing to the aforementioned factors, the skin antiseptic products market in North America is expected to grow significantly over the forecast period.
Skin Antiseptic Products Industry Overview
The skin antiseptic products market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are BD, 3M, Ecolab, Schülke & Mayr GmbH, Sage Products LLC, Johnson & Johnson, and B. Braun Melsungen AG.
Skin Antiseptic Products Market Leaders
-
BD
-
B. BRAUN MELSUNGEN AG
-
Ecolab
-
3M
-
Johnson & Johnson
*Disclaimer: Major Players sorted in no particular order
Skin Antiseptic Products Market News
- In March 2022, PDI Healthcare launched novel, innovative disinfectants, Sani-24 Germicidal Disposable Wipe, Sani-HyPerCide Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray, to help infection prevention professionals in the fight against rising healthcare-associated infections (HAIs).
- In January 2022, ESTA Technology launched ULTRABloom foam hand sanitizer, which is alcohol-free and provides protection against bacteria, yeast, viruses, fungi, and mould.
Skin Antiseptic Products Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Hospital-acquired Infections
4.2.2 Increasing Number of Surgeries
4.3 Market Restraints
4.3.1 Side effects and risk of Permeability
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
5.1 By Formulation
5.1.1 Alcohols
5.1.2 Chlorhexidine
5.1.3 Iodine
5.1.4 Other Formulations
5.2 By Type
5.2.1 Solutions
5.2.2 Swab Sticks
5.2.3 Wipes
5.3 By Application
5.3.1 Surgeries
5.3.2 Injection
5.3.3 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton Dickinson and Company
6.1.2 3M Company
6.1.3 Ecolab Inc.
6.1.4 Schelke & Mayr GmbH
6.1.5 Sage Products LLC
6.1.6 Johnson & Johnson
6.1.7 B. Braun Melsungen AG
6.1.8 Reckitt Benckiser Group PLC
6.1.9 Purdue Pharma L.P.
6.1.10 PSK Pharma Pvt.Ltd
6.1.11 Kimberly-Clark
6.1.12 Sirmaxo Chemicals Pvt. Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Skin Antiseptic Products Industry Segmentation
As per the scope of the report, skin antiseptics are used to protect against germs and remove existing microorganisms in their bodies. The process of managing infections is considered a crucial element that keeps people and non-living things free from germs. The skin antiseptic products market is segmented by formulation (alcohols, chlorhexidine, iodine, and other formulations), type (solutions, swab sticks, and wipes), application (surgeries, injection, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Formulation | |
| Alcohols | |
| Chlorhexidine | |
| Iodine | |
| Other Formulations |
| By Type | |
| Solutions | |
| Swab Sticks | |
| Wipes |
| By Application | |
| Surgeries | |
| Injection | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Skin Antiseptic Products Market Research FAQs
What is the current Global Skin Antiseptic Products Market size?
The Global Skin Antiseptic Products Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Global Skin Antiseptic Products Market?
BD, B. BRAUN MELSUNGEN AG, Ecolab, 3M and Johnson & Johnson are the major companies operating in the Global Skin Antiseptic Products Market.
Which is the fastest growing region in Global Skin Antiseptic Products Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Skin Antiseptic Products Market?
In 2024, the North America accounts for the largest market share in Global Skin Antiseptic Products Market.
What years does this Global Skin Antiseptic Products Market cover?
The report covers the Global Skin Antiseptic Products Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Skin Antiseptic Products Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Restriction Enzyme Industry Report
Statistics for the 2024 Restriction Enzyme market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Restriction Enzyme analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
